drugset / Trial / NCT07172893
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic non-healing wounds in patients with chronic non-healing ulcers.
Timeline
- Start
- 2025-12-10
- Primary completion
- 2027-02-21
- Completion
- 2027-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DermaBind TL | Other / unclassified | — | Topical |